Haghighi Lab

Laboratory of Medical Epigenetics

Research

haghighiIn my laboratory, my team and I study how environmental signals and insults are interpreted by our cells. Our mechanism of focus is epigenetics. Epigenetics refers to the functionally relevant modifications to the genome that do not involve a change in the DNA sequence. Epigenetics is the bridge connecting the environment and genetics, regulating gene expression and cellular response to environmental cues throughout our lifespan. To better understand the role of environmental factors in brain function and dysfunction, we investigate epigenetics, in particular, DNA methylation dynamics during early development and adulthood. We are interested in how physical and/or psychosocial stress can induce epigenetic abnormalities that later lead to neuropathological and psychiatric symptoms. Physical stressors like traumatic brain injury can enhance or contribute to these abnormalities, and psychosocial stressors often precipitate depression and heightened suicide risk. Applying both genomics and computational approaches, we use a combination of animal and human studies to identify genes and genetic pathways that undergo sustained transcriptional regulatory changes in response to such environmental insults.

Contact Us

Haghighi Laboratory
Fatemeh Haghighi, PhD
Associate Professor, Neuroscience
Associate Professor, Psychiatry
Location
Lab: James J. Peters Veterans Affairs Medical Center, Room 5F-07 & 4F-21
Office: ICAHN 9-20D
Phone
Office: 212.659.5903
Lab: 212.659.5903
Lab fax: 718.584.9000 ext 6015
Email

Connect With Us

Chromatin Dynamics in Primate Brain Development

CpA methylation defines neuronal developmental trajectories

The role of chromatin dynamics in neurodevelopment is widely recognized. Environmental insults during early development pre and peri natally can induce long lasting chromatin modifications resulting in indelible effects on health and disease later in life. Knowledge of the chromatin dynamics of human neurodevelopment is essential for interpretation of epigenetic findings for neurodevelopmental disorders such as autism, schizophrenia, major depression, and anxiety. Our research focuses on delineating DNA methylation and chromatin accessibility dynamics during normal brain development in mammalian genomes. This research has contributed to seminal findings that showed dynamic changes throughout development with non-CG methylation (mCH) accumulating in neurons, but not glia, which then become the dominant form of methylation in the human neuronal genome. Our ongoing research efforts are concerned with characterizing neuronal DNA methylation and chromatin accessibility patterns at single-base resolution within the prefrontal cortex of human and rhesus macaque using state of the art ultra-high throughput sequencing technology. By identifying genomic compartments subject to epigenetic neurodevelopmental regulation, these data provide the framework for interpretation of findings from investigations of neurodevelopmental disorders. This research is foundational for studies of early effects of environment on molecular circuitry of the developing primate brain. How epigenetic mechanisms contribute to the risk for neurodevelopmental and neuropsychiatric disorders is an important focus and a natural progression of our continuing work.

Blast Related Mild Traumatic Brain Injury

Traumatic brain injury affects 1.7 million Americans each year. Of note, mild TBI is a significant contributor to death and disease in the armed forces and the veteran population returning from wars in Iraq and Afghanistan. It has been estimated that that 10-20% of these returning veterans have suffered a mild TBI and, in many cases, were not diagnosed prior to discharge. Of note, mild TBI is of growing importance to public health with associated comorbid psychopathological symptoms including mood and anxiety disorders, post-traumatic stress disorder, and suicidality. Specifically, research in the lab is focused on identifying transcriptional regulatory changes associated with blast exposure. While blast-related mild TBIs are most well-known in a military setting, they have become increasingly prevalent in the civilian population. Through parallel research tracks involving both rodent and human studies of US Military personnel with exposure to repeated blast in collaboration with the Department of Defense, we have studies underway to identify both acute and chronic transcriptional regulatory changes associated with blast exposure.

Animal model of repeated blast overpressure

Blast tube for administration of blast overpressure

To explore the epigenetic changes associated with blast exposure, our projects employ state-of-the-art sequencing and bioinformatics technologies to identify the biochemical changes that influence how genes are expressed in response to blast exposure and associated mild traumatic brain injury (mTBI). Using proven rodent models of blast-related mTBI, we study acute and chronic molecular changes in brain tissue and peripheral blood to shed light on the neurobiological mechanisms underlying mTBI. We profile DNA methylation on a genome-wide scale with techniques like Reduced Representation Bisulfite (RRBS) sequencing to identify transcriptional regulatory regions that are aberrantly methylated following chronic blast exposure. We further investigate the functional significance of these epigenetic changes by performing transcriptional profiling via RNA-seq. This work will aid in discovery of potential gene targets for therapeutic intervention in acute and chronic mTBI.

Human Studies of Effects of Repeated Blast

Exposure to blast during breaching

Translating the findings from our animal studies, we are further interested in determining whether the related molecular epigenetic changes in genes and genetic pathways also detected in human populations. In collaboration with the DoD, we study populations with repeated occupational exposure to low-level blast over multiple exposure events. Profiling DNA methylation and transcriptional changes associated with these exposure events, we are able to characterize the underlying genetic pathways that are influenced by repeated exposure. Because this is a translational study, we are able to link findings using results from both human and clinically relevant animal models as a guide to discover gene targets, thus providing insight into the molecular mechanism of blast-related mTBI.

Neurobiology of Suicide

With the high incidence of suicide amongst individuals with mild TBI, we have developed a complementary research program focusing on neuroinflammatory mechanisms in suicidal behavior. Since suicide is the tenth leading cause of death in the United States and a leading cause of death among US veterans, understanding the etiological basis of suicide risk is critical. Biological markers and environmental risk factors such as TBI and chronic stress likely interact in a complex manner that might benefit from an investigation using genomics approaches that can examine gene by environment interactions. Our research approaches this in a multi-pronged fashion, undertaking clinical, human postmortem, and large-scale data analytic strategies. Our clinical studies involve investigation of genome-scale epigenetics (specifically DNA methylation), transcriptional (RNA-seq), and inflammatory signatures in suicidal veterans.

Through subsequent follow up assessments, we seek to determine how transcriptional regulation is altered following treatment as usual. This observational longitudinal study is a powerful approach to identifying the dynamics of biological markers associated with suicidal behavior. Together, the transcriptional regulatory and inflammatory biological markers of suicide risk will identify objective measures that we can use in clinical settings to identify risk factors of suicide and to determine the efficacy of treatment course and response.

The clinical suicide studies in the lab are also augmented by postmortem human studies. Postmortem studies of suicide victims are vital to our understanding of the neuropathology of suicide. Our lab is focused on delineating the DNA methylation changes that occur in the brains of suicide victims, as compared to non-suicidal individuals in a cell-specific manner. By isolating neuronal and glial cell populations from postmortem brain tissue from both suicidal and non-suicidal individuals, we hope to identify abnormal changes in DNA methylation that are unique to suicide neuropathology. Data generated from this project will accelerate the pace of discovery by introducing an additional layer of information concerning the regulatory circuitry of genes involved in the diathesis of suicide and suicidal behavior.

Isolated microvessels from postmortem human brain.

Further along our postmortem line of research, we investigate whether the blood-brain barrier (BBB) may be compromised in suicidal behavior. Relatively static changes in systemic or CNS immunity, possibly related to psychiatric diseases, injury, or chronic stressors (e.g. combat, abuse) could compromise the BBB. Increased cross-talk between peripheral and central immune system in a feed-forward cycle could culminate in behavioral changes that include suicide. Such processes can be detected by noninvasive brain imaging and blood biomarkers of suicide. Using isolated microvessels from suicide victims and non-psychiatric controls, we assess the blood-brain barrier at the molecular level using genome-scale epigenetics, transcriptomics, and proteomics assays. Once the role of BBB in suicide is established through proteomics, BBB impairment can be detected by routine radiological procedures or by levels of CNS proteins (e.g., S100B in serum, microglial activation can be detected by PET scan, cytokines can be measured in blood or cerebrospinal fluid). Ideally, combinations of these tests could identify who is at risk for suicide and when, allowing for timely intervention. Ultimately, risk of suicide may be reduced by interventions affecting BBB and neuroinflammation.

In our most recent avenue of suicide risk exploration, our lab was selected to join the analytic effort of the Million Veteran Program consortium to study genetic factors and suicidal subtypes using data collected on approximately 600,000 veterans to date. The availability of such big data will allow us to develop machine learning algorithms for identification of suicidal subtypes and biological risk factors associated with suicidal behavior. Taken together, this multi-faceted research strategy offers an integrated approach to gain insight into the clinical features and molecular mechanisms of suicidal behavior.

Neurobiology of Sleep Disturbances in TBI and Suicide

Sleep disturbances are common following traumatic brain injury, and occur particularly frequently in veterans who have sustained traumatic brain injury. In epidemiological studies of military members with blast-related TBI, sleep disturbances can mediate subsequent development of PTSD and depression, both of which can increase suicidal risk. Because TBI, PTSD, and depression have overlapping symptoms, especially symptoms associated with sleep problems, it is difficult to know whether the presence of one condition is a precursor to another. Given the preponderance of sleep disturbances following TBI, this may be an early indicator of development of subsequent psychiatric disorders and heightened risk for suicidal behavior. In our lab, we are developing a rodent model of blast and sleep by performing electroencephalographic sleep recordings on rodents with repeated blast exposure. This will allow us to determine changes in sleep architecture associated with blast.  Furthermore, we are determining DNA methylation and transcriptional changes in brain regions key in sleep circuitry. The data generated by this project will further our understanding of sleep changes accompanying mild TBI and the associated molecular mechanisms.

Features and Updates

Featured Publication

Haghighi Fatemeh, Ge Yongchao, Chen Sean, Xin Yurong, Umali Michelle U., De Gasperi Rita, Gama Sosa Miguel A., Ahlers Stephen T., and Elder Gregory A. Neuronal DNA Methylation Profiling of Blast-Related Traumatic Brain Injury. Journal of Neurotrauma. July 2015, 32(16): 1200-1209. doi:10.1089/neu.2014.3640.

Long-term molecular changes in the brain resulting from blast exposure may be mediated by epigenetic changes, such as deoxyribonucleic acid (DNA) methylation, that regulate gene expression.

Funding and Awards

1I01CX001728-01A1 Haghighi (PI) 

(start date pending) – 03/31/2020     

VA Merit    

“Identifying Bio-signatures of Suicidal Subtypes in Veterans”

Using the Million Veteran Program Gamma computational platform, we propose a unique combination of statistical and machine learning methods to develop our subtypes based on Electronic Patient Records and self-reports; followed by a careful genomic analysis of the resulting subtypes compared to two control groups chosen from the same cohort, with and without mental health disorders. This project aims to develop sophisticated diagnosis tools for preventing future suicidal behavior in US Veterans at high risk. Moreover, the biomarkers identified from this study will be directly applied for validation in the PI and co-investigators’ longitudinal study of high-risk VA patients, a natural validation sample from the same population; promising a combination of the power of both studies.

1I01RX001705-01A1 Haghighi (PI)         

01/01/2016-5/31/2019

VA Merit         

“Epigenetic Mechanisms in Blast Related Traumatic Brain Injury”

This study aims to identify epigenetic and transcriptional changes that influence how genes are expressed in response to blast-related mild traumatic brain injury (mTBI).  This will be achieved by comparing the blood and brain samples from a proven animal model of blast-related mTBI to blood samples of a subpopulation of individuals, referred to as breachers with repeated blast exposure over career in the military and law enforcement service.  The results will shed light on the neurobiological mechanisms underlying blast-related mild TBI and may help identify potential gene targets for use in future therapeutic intervention in TBI-related neurological and psychiatric symptoms associated with mood disorders and risk of suicide.

1I01CX001395-01A1 Haghighi (PI)

10/01/2016-5/31/2020

VA Merit

“DNA Methylation and Inflammatory Signatures Associated with Suicide Risk and Treatment in US Veterans”

Suicide is a leading cause of death among US veterans. In the veteran population, sustained exposure to stressful events that occur during combat, military service or post-deployment stressful situations related to readjustment to civilian life contribute to risk of suicide. Epigenetics is the bridge connecting environment with genetics, by mediating the influence of environmental factors such as stress in altered regulation of gene expression related to suicide. We will investigate inflammatory and DNA methylation patterns associated with suicide risk in veterans undergoing psychiatric treatment, and through subsequent follow-up studies, we will assess how inflammatory and DNA methylation levels are altered following treatment –in an effort to identify biological markers of suicide risk and treatment response.

1I01BX003794-01A1 Haghighi (PI)    

01/01/2018- 12/31/2021

VA Merit        

“Neuroinflammatory and Epigenetic Mechanisms of Blood-Brain Barrier Compromise in Suicide”

Suicide is a major health crisis within our Veteran population. In suicide victims, the blood-brain barrier may be compromised, and understanding the biological mechanisms linking stress, the blood-brain barrier, and suicidal behavior is critical to developing diagnostic tools and preventative treatments. This study aims to assess the blood-brain barrier in suicide victims at the molecular and neuroanatomical levels.

P50 MH090964  Mann (PI)

7/19/2013-6/30/2018

NIMH

“Conte Center: Neurobiological and Developmental Antecedents to Suicidal Behavior”

The Conte Center will employ a multidisciplinary approach to study how reported childhood adversity can mold the diathesis for suicidal behavior. These projects will help elucidate how early adverse experiences affect gene expression and brain biology to increase risk of suicidal behavior later in life.

R01MH094774-02  Haghighi (PI)

09/1/2011 – 8/30/2017

NIMH

“Neurodevelopmental Profiling of the Epigenome in Human and Rhesus”

In this study, we will investigate the epigenetic landscape of the brain throughout development. We will characterize those epigenetic signatures that define neurodevelopmental trajectories, which are conserved in human and non-human primates.

American Foundation for Suicide Prevention   Haghighi (PI)

3/1/2013-12/30/2015

“Neuronal DNA Methylation Signatures of the Suicide Brain”

This study investigates epigenetic mechanisms, specifically DNA methylation, that can modulate gene expression, which has gained wide recognition in recent years as mediators of environmental effects on suicide risk.

R01 EY13435 Allikmets (PI)

9/1/2010-8/31/2015
Genetic Susceptibility to Age-Related Macular Degeneration”                          

Age-related macular degeneration (AMD) is a multifactorial, complex disorder associated both with environmental and genetic factors.

R01MH040695-20 Mann (PI)

4/22/2010-1/31/2015

“Neurobiology of Depression and Antidepressants (NODA)”

The research seeks to define an abnormality in serotonin system regulation involving over expression of the 5-HT1A auto receptor that results in reduced serotonin release and post-synaptic super sensitivity in major depressive disorders and in bipolar disorder.

Meet the PI

Getting a closer look… Medusa bust at the Basilica Cistern in Istanbul, Turkey

Dr. Haghighi obtained her PhD in Statistical Genetics and Postdoctoral Fellowship in Bioinformatics from Columbia University. She is an Associate Professor at the Icahn School of Medicine at Mount Sinai and a Senior Researcher at the James J. Peters VA Medical Center (JJPVAMC). Her research focuses on understanding how environmental exposures, such as stress and injury, result in molecular changes and disease. To this end, she has spearheaded research studies at the JJPVAMC investigating the effect of repeated blast on inducing aberrant gene regulation. Additionally, she has developed a robust suicide research portfolio examining the neuroinflammatory and epigenetic changes associated with chronic stress and risk of suicide, both in the peripheral and central nervous systems.

Outside of work, Dr. Haghighi enjoys traveling and being a foodie (often at the same time) and keeping up with the latest accessible technology as a blind scientist with Stargardt disease.

Meet the Team

 InBae (Brian) Choi

InBae (Brian) Choi

Biological Research Technician

inbae.choi@va.gov

 Jonathan Horowitz

Jonathan Horowitz

Associate Researcher

Jonathan.horowitz@mssm.edu

Natalia Mendelev

Natalia Mendelev

Associate Researcher II

natalia.mendelev@mssm.edu

Zac Chatterton

Zac Chatterton

Adjunct Assistant Professor

zac.chatterton@mssm.edu

Sharon Alter

Sharon Alter

Clinical Research Coordinator

sharon.alter@va.gov

Rachel Harris

Rachel Harris

Clinician Assessor

rachel.harris6@va.gov

Amanda Vitale

Amanda Vitale

Research Assistant

amanda.vitale@mssm.edu

Maria Milekic

Maria Milekic

Adjunct Assistant Professor

maria.milekic@gmail.com

Akram Yazdani

Akram Yazdani

Post-Doctoral Research Scientist

akram.yazdani@mssm.edu

Zhaoyu Wang

Zhaoyu Wang

Data Coordinator

zhaoyu.wang@mssm.edu

Jennifer Blaze

Jennifer Blaze

Post-Doctoral Research Scientist

jennifer.blaze@mssm.edu

Tatiana Schnieder

Tatiana Schnieder

Post-Doctoral Research Scientist

tatianaschnieder@gmail.com

Job Openings

Job opportunities are available in the Laboratory of Medical Epigenetics. Internationally regarded for its dedication to medical science, Mount Sinai is home to an array of leading research institutes, centers, and laboratories, all of which work toward rapidly translating advances in basic science into innovative patient care. Mount Sinai’s Fishberg Department of Neuroscience, a major component of Mount Sinai’s Friedman Brain Institute, sponsors innovative research in basic and translational neuroscience at the molecular, cellular, systems, and behavioral levels. The Haghighi laboratory is studying the epigenetic profiles of human brain development and its emerging role in gene regulation, as well as its fundamental importance for our understanding of normal and pathological neuronal function. Epigenetic patterns in the genome vary among tissues and cell types in normal and pathological states.

A major unanswered question is how epigenetics plays a role in neuronal development and how alterations in normal epigenetic processes during development lead to neurodevelopmental diseases such as autism and schizophrenia. Next-gen sequencing technologies now allow a global view of whole genome epigenetic profiles. Studies involve statistical and bioinformatic analyses of data from whole genome DNA and histone methylation profiling via BS-seq and ChIP-seq to detect differentially methylated regions associated with disease and their potential function through genomic data mining. This interdisciplinary group offers an excellent environment to uncover new fundamental principles and regulatory mechanisms in this emerging area of neural epigenetics.